Skip to main content

and
  1. Article

    Open Access

    Targeting the ERG oncogene with splice-switching oligonucleotides as a novel therapeutic strategy in prostate cancer

    The ERG oncogene, a member of the ETS family of transcription factor encoding genes, is a genetic driver of prostate cancer. It is activated through a fusion with the androgen-responsive TMPRSS2 promoter in 50% o...

    Ling Li, Lisa Hobson, Laura Perry, Bethany Clark, Susan Heavey in British Journal of Cancer (2020)